Wecom Fiber partners with gaiia to power high-speed fiber network expansion

QUEBEC, Jan. 22, 2025 (GLOBE NEWSWIRE) — Wecom Fiber, a leading broadband provider that delivers fiber, telecommunications, and internet services to residential and business customers throughout the Southwestern United States, has partnered with gaiia to manage their operations as they embark on rapid growth plans and expand their fiber network, including a flagship project to […]

NTHU Develops Cellular Transport “Freeze” Technique Capable of Blocking Virus Invasion

HSINCHU, Taiwan, Jan. 22, 2025 (GLOBE NEWSWIRE) — The functioning of human cells resembles the way a city relies on a precise transport system to deliver various things and materials to their correct locations. However, the high speed of this transport system in the human body has created significant challenges for the scientists studying it.

AB Science will participate in the Biomed Forum investors conference

(Paris:AB), PRESS RELEASE AB SCIENCE WILL PARTICIPATE IN THE BIOMED FORUM INVESTORS CONFERENCE Paris, 22 january 2024, 7pm CET AB Science SA (Euronext – FR0010557264 – AB) announced that its management team will participate in the upcoming edition of the Biomed Forum, a conference for institutional investors. Organized by AllInvest Securities, this event will take

Transaction in Own Shares

(Euronext Amsterdam:SHELL),(LSE:SHEL),(NYSE:SHEL), Transaction in Own Shares 22 January, 2025 • • • • • • • • • • • • • • • • Shell plc (the 'Company') announces that on 22 January 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of

Charles Eitel Announces the Grant for Finance and Accounting to Inspire Future Innovators in Organizational Leadership

NAPLES, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) — The Charles Eitel Grant for Finance and Accounting is now accepting applications from undergraduate students nationwide who are pursuing degrees in finance or accounting. Renowned business leader and visionary Charles Eitel, with over 40 years of experience in transforming organizations and driving sustainable growth, established this grant

DTE Energy announces electric reliability progress: Customers experienced a 70% improvement in time spent without power in 2024

(NYSE:DTE), Detroit, Jan. 22, 2025 (GLOBE NEWSWIRE) — DTE Energy today reported the progress it made in 2024 in building a smarter, stronger, and more resilient electric grid for its customers. Due to the impact of enhanced work and increased investment in the electric grid, coupled with less extreme weather, DTE customers experienced a nearly

Shareholders that lost money on Joint Stock Company Kaspi.kz(KSPI) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

(NASDAQ:KSPI), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Joint Stock Company Kaspi.kz (“Joint Stock Company Kaspi.kz” or the “Company”) (NASDAQ: KSPI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Joint Stock Company Kaspi.kz investors who were adversely affected

Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) should contact Levi & Korsinsky about pending Class Action – KYTX

(NASDAQ:KYTX), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were adversely affected by alleged securities

Lost Money on BioAge Labs, Inc.(BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

(NASDAQ:BIOA), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and a protein engineering and discovery research facility to Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TXL). https://mma.prnewswire.com/media/2603972/ImaginAb_Main_Logo_Logo.jpg Following the closing of this transaction, ImaginAb Inc., will focus on developing its lead imaging

Scroll to Top